Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             31 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions Opriessnig, Tanja

35 2 p. 248-254
artikel
2 Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia Reyes, J.F.

35 2 p. 345-352
artikel
3 Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep van Rijn, Piet A.

35 2 p. 231-237
artikel
4 Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis Young, Barnaby

35 2 p. 212-221
artikel
5 Editorial Board/Aims and Scope
35 2 p. IFC
artikel
6 Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants Chong, Yong

35 2 p. 255-263
artikel
7 Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae) [Vaccine 30 (2012) 5688–5694] Grisez, Luc

35 2 p. 203
artikel
8 Efficacy of the GMZ2 malaria vaccine in African children Milligan, Paul

35 2 p. 202
artikel
9 Flagellin enhances the immunoprotection of formalin-inactivated Edwardsiella tarda vaccine in turbot Liu, Xiaohong

35 2 p. 369-374
artikel
10 gp85 protein vaccine adjuvanted with silica nanoparticles against ALV-J in chickens Cheng, Jia

35 2 p. 293-298
artikel
11 Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion Pilkinton, Mark A.

35 2 p. 329-336
artikel
12 Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization Moseri, Adi

35 2 p. 222-230
artikel
13 Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation Datta, Dibyadyuti

35 2 p. 264-272
artikel
14 Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens Maruggi, Giulietta

35 2 p. 361-368
artikel
15 Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs Fairbrother, John Morris

35 2 p. 353-360
artikel
16 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults Song, Joon Young

35 2 p. 313-320
artikel
17 Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection de Vries, Rory D.

35 2 p. 238-247
artikel
18 Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country Akhtar, Marjahan

35 2 p. 321-328
artikel
19 Knowledge and attitudes towards influenza vaccination of health care workers in emergency services Hulo, Sébastien

35 2 p. 205-207
artikel
20 Maternal BCG scar is associated with increased infant proinflammatory immune responses Mawa, Patrice Akusa

35 2 p. 273-282
artikel
21 Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England Christensen, Hannah

35 2 p. 208-211
artikel
22 Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial Iro, Mildred A.

35 2 p. 395-402
artikel
23 Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand Chotpitayasunondh, Tawee

35 2 p. 299-304
artikel
24 Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine Poore, Elizabeth A.

35 2 p. 283-292
artikel
25 Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach Pan-Ngum, Wirichada

35 2 p. 403-409
artikel
26 Response to request for Corrigendum to “Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae)”. [Vaccine 30(38) (2012) 5688–5694] Karlsen, Marius

35 2 p. 204
artikel
27 Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study Frenck Jr, Robert W.

35 2 p. 375-384
artikel
28 Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial Creech, C. Buddy

35 2 p. 385-394
artikel
29 Sequential immunization with consensus influenza hemagglutinins raises cross-reactive neutralizing antibodies against various heterologous HA strains Zhou, Hui

35 2 p. 305-312
artikel
30 Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model Xu, Qingfu

35 2 p. 337-344
artikel
31 When should a time at risk start in efficacy malaria vaccine trials? Ejigu, Dawit Asmamaw

35 2 p. 201
artikel
                             31 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland